Yamaguchi H - Search Results

1

The high expression of Fractalkine results in a better prognosis for colorectal cancer patients.

Ohta M, Tanaka F, Yamaguchi H, Sadanaga N, Inoue H, Mori M. Ohta M, et al. Among authors: yamaguchi h. Int J Oncol. 2005 Jan;26(1):41-7. Int J Oncol. 2005. PMID: 15586223

2

Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma.

Mashino K, Sadanaga N, Yamaguchi H, Tanaka F, Ohta M, Shibuta K, Inoue H, Mori M. Mashino K, et al. Among authors: yamaguchi h. Cancer Res. 2002 May 15;62(10):2937-41. Cancer Res. 2002. PMID: 12019175

3

Stimulation of CD40 inhibits Fas- or chemotherapy-mediated apoptosis and increases cell motility in human gastric carcinoma cells.

Yamaguchi H, Tanaka F, Sadanaga N, Ohta M, Inoue H, Mori M. Yamaguchi H, et al. Int J Oncol. 2003 Dec;23(6):1697-702. Int J Oncol. 2003. PMID: 14612943

4

Expression of cancer-testis antigen (CTA) genes in intrahepatic cholangiocarcinoma.

Utsunomiya T, Inoue H, Tanaka F, Yamaguchi H, Ohta M, Okamoto M, Mimori K, Mori M. Utsunomiya T, et al. Among authors: yamaguchi h. Ann Surg Oncol. 2004 Oct;11(10):934-40. doi: 10.1245/ASO.2004.01.029. Ann Surg Oncol. 2004. PMID: 15466353

5

Expression of the TRAG-3 gene in human esophageal cancer: the frequent synchronous expression of MAGE-3 gene.

Ohta M, Tanaka F, Sadanaga N, Yamaguchi H, Inoue H, Mori M. Ohta M, et al. Among authors: yamaguchi h. Oncol Rep. 2006 Jun;15(6):1529-32. Oncol Rep. 2006. PMID: 16685391

6

Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.

Tanaka F, Yamaguchi H, Haraguchi N, Mashino K, Ohta M, Inoue H, Mori M. Tanaka F, et al. Among authors: yamaguchi h. Int J Oncol. 2006 Nov;29(5):1263-8. Int J Oncol. 2006. PMID: 17016660

7

Intratumoral injection of dendritic cells after treatment of anticancer drugs induces tumor-specific antitumor effect in vivo.

Tanaka F, Yamaguchi H, Ohta M, Mashino K, Sonoda H, Sadanaga N, Inoue H, Mori M. Tanaka F, et al. Among authors: yamaguchi h. Int J Cancer. 2002 Sep 20;101(3):265-9. doi: 10.1002/ijc.10597. Int J Cancer. 2002. PMID: 12209978

8

Effective strategy of dendritic cell-based immunotherapy for advanced tumor-bearing hosts: the critical role of Th1-dominant immunity.

Mashino K, Sadanaga N, Tanaka F, Ohta M, Yamaguchi H, Mori M. Mashino K, et al. Among authors: yamaguchi h. Mol Cancer Ther. 2002 Aug;1(10):785-94. Mol Cancer Ther. 2002. PMID: 12492111

9

Identification of HLA-A24-restricted CTL epitope from cancer-testis antigen, NY-ESO-1, and induction of a specific antitumor immune response.

Yamaguchi H, Tanaka F, Ohta M, Inoue H, Mori M. Yamaguchi H, et al. Clin Cancer Res. 2004 Feb 1;10(3):890-6. doi: 10.1158/1078-0432.ccr-1086-3. Clin Cancer Res. 2004. PMID: 14871964

10

Preoperative u-PAR gene expression in bone marrow indicates the potential power of recurrence in breast cancer cases.

Mimori K, Kataoka A, Yamaguchi H, Masuda N, Kosaka Y, Ishii H, Ohno S, Mori M. Mimori K, et al. Among authors: yamaguchi h. Ann Surg Oncol. 2009 Jul;16(7):2035-41. doi: 10.1245/s10434-009-0465-x. Epub 2009 Apr 30. Ann Surg Oncol. 2009. PMID: 19404710

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,014 results

Search Page

Filters